Abstract:Approximately half of patients with cancer receive radiotherapy and, as cancer survivorship increases, the low rate of radiation-associated sarcomas is rising. Pharmacologic inhibition of p53 has been proposed as an approach to ameliorate acute injury of normal tissues from genotoxic therapies, but how this might impact the risk of therapy-induced cancer and normal tissue injuries remains unclear. We utilized mice that express a doxycycline (dox)-inducible p53 short hairpin RNA to reduce Trp53 expression temporarily during irradiation. Mice were placed on a dox diet 10 days prior to receiving 30 or 40 Gy hind limb irradiation in a single fraction and then returned to normal chow. Mice were examined weekly for sarcoma development and scored for radiation-induced normal tissue injuries. Radiation-induced sarcomas were subjected to RNA sequencing. Following single high-dose irradiation, 21% of animals with temporary p53 knockdown during irradiation developed a sarcoma in the radiation field compared with 2% of control animals. Following high-dose irradiation, p53 knockdown preserves muscle stem cells, and increases sarcoma development. Mice with severe acute radiation-induced injuries exhibit an increased risk of developing late persistent wounds, which were associated with sarcomagenesis. RNA sequencing revealed radiation-induced sarcomas upregulate genes related to translation, epithelial-mesenchymal transition (EMT), inflammation, and the cell cycle. Comparison of the transcriptomes of human and mouse sarcomas that arose in irradiated tissues revealed regulation of common gene programs, including elevated EMT pathway gene expression. These results suggest that blocking p53 during radiotherapy could minimize acute toxicity while exacerbating late effects including second cancers. Significance: Strategies to prevent or mitigate acute radiation toxicities include pharmacologic inhibition of p53 and other cell death pathways. Our data show that temporarily reducing p53 during irradiation increases late effects including sarcomagenesis.

Temporal mTOR inhibition protects Fbxw7-deficient mice from radiation-induced tumor development.

Expression Profiling Reveals Transcriptional Regulation by Fbxw7/Mtor Pathway in Radiation-Induced Mouse Thymic Lymphomas

FBXW7 inactivation induces cellular senescence via accumulation of p53

[RAD001 Reverses Radio-Resistance and Exerts Synergistic Tumor Inhibition with 5-Fluorouracil].

Data from Genetic Ablation of <i>rbm38</i> Promotes Lymphomagenesis in the Context of Mutant P53 by Downregulating PTEN

Abstract 2988: Loss of Rbm38 Cooperates with Mutant P53 to Promote Lymphomagenesis Through Downregulation of Pten

The Mtor–s6k Pathway Links Growth Signalling to DNA Damage Response by Targeting RNF168

FBXW7 Confers Radiation Survival by Targeting P53 for Degradation

FBXW7 Targets mTOR for Degradation and Cooperates with PTEN in Tumor Suppression

Fbxw7/Cdc4 is a p53-dependent, haploinsufficient tumour suppressor gene

Transient Inhibition of Mtorc1 Signaling Ameliorates Irradiation-Induced Liver Damage

Pten Regulates Aurora-A and Cooperates with Fbxw7 in Modulating Radiation-Induced Tumor Development

Temporary Knockdown of p53 During Focal Limb Irradiation Increases the Development of Sarcomas

Synergistic Effects of Rapamycin and Fluorouracil to Treat a Gastric Tumor in a PTEN Conditional Deletion Mouse Model

Inactivation of ribosomal protein S27-like confers radiosensitivity via the Mdm2-p53 and Mdm2–MRN–ATM axes

Inhibition of Mtorc1 Signaling Protects Kidney from Irradiation-Induced Toxicity Via Accelerating Recovery of Renal Stem-Like Cells

The Mtor Inhibitor Rapamycin Suppresses DNA Double-Strand Break Repair.

MHY1485 enhances X-irradiation-induced apoptosis and senescence in tumor cells

Inhibition of Mtor Enhances Radiosensitivity of Lung Cancer Cells and Protects Normal Lung Cells Against Radiation

p53 haploinsufficiency and increased mTOR signalling define a subset of aggressive hepatocellular carcinoma